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SObjective: We reviewed our experience of iatrogenic chylothorax after pulmonary resection for primary lung
cancer to evaluate a low-fat diet management strategy.
Methods: From October 2003 to March 2010, 1580 patients underwent lobectomy or greater resection and sys-
tematic mediastinal lymph node dissection for primary lung cancer at our institution. Chylothorax was diag-
nosed on the basis of chylous leakage from the chest tube and was confirmed by presence of triglycerides
(>110 mg/dL) in the drainage fluid. We initially treated the patients with chylothorax conservatively with
a low-fat diet (fat intake<10 g/day). If chest tube drainage produced>500 mL of chylous fluid during the first
24 hours after the initiation of the low-fat diet, surgical intervention was performed. If chest tube drainage pro-
duced>300 mL/day of chylous fluid after 3 days of a low-fat diet, we performed pleurodesis by injecting a prep-
aration of OK-432, a penicillin-treated lyophilized preparation of a Streptococcus strain into the thoracic cavity
through a chest tube.
Results: Postoperative chylothorax developed in 37 patients (2.3%), 33 men and 4 women, with a median age of
69 years (range, 44-84). The initial procedures were pneumonectomy in 1 patient and lobectomy in 36 patients.
In 23 patients (62%), their condition resolved with the low-fat diet only. A total of 10 patients underwent
OK-432 pleurodesis, and 8 of these were cured with continuation of the low-fat diet. These 31 patients who re-
sponded to conservative treatment (84%) resumed a normal diet at a median of 10 days (range, 5-27) after the
chylothorax diagnosis. The remaining 6 patients (16%) underwent reoperation and were discharged at a median
of 18 days (range, 14-33) after the initial surgery.
Conclusions: A low-fat diet and OK-432 pleurodesis achieved positive results in>80% of patients with chy-
lothorax after pulmonary resection with systematic mediastinal lymph node dissection within 4 weeks after the
initial surgery. More than 500 mL of chylous fluid during the first 24 hours after the initiation of the low-fat diet
was valid as an indication of the need for surgical intervention. (J Thorac Cardiovasc Surg 2013;146:571-4)Earn CME credits at
http://cme.ctsnetjournals.org
Postoperative chylothorax is a relatively rare, but well-
known, complication of thoracic surgery. However, because
of its rare occurrence, its management strategy has not been
well established, and a practical strategy is needed.
In 2002, we reviewed our experiences with iatrogenic
chylothorax after pulmonary resection for lung cancer to
evaluate our treatment strategy and to identify the factors
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The Journal of Thoracic and Capatients recovered fully with a conservative strategy of
complete oral intake cessation and total parenteral nutrition
(TPN), early surgical intervention was indicated if chest
tube drainage of>500 mL of chylous fluid was observed
during the first 24 hours after complete oral intake cessation
and the initiation of TPN.1 Because of recent reports that
have advocated a low-fat diet for reducing chylous
flow,2,3 we developed a low-fat diet management strategy
for postoperative patients with chylothorax and collected
the data regarding the outcomes of patients with iatrogenic
chylothorax after pulmonary resection with systematic me-
diastinal lymph node dissection for lung cancer.METHODS
From October 2003 through March 2010, 1580 patients underwent lo-
bectomy or greater resection plus systematic lymph node dissection for pri-
mary lung cancer at our hospital. A diagnosis of chylothorax was
determined by chylous leakage from a chest tube and was confirmed by
the presence of an elevated triglyceride level (>110 mg/dL) in the drainage
fluid. The drainage volume was not considered in the chylothorax diagno-
sis. Postoperative chylothorax developed in 37 patients (2.3%), and these
patients constituted the subjects of the present study.
We treated these patients conservatively with a low-fat diet (fat< 10
g/day), prohibiting any consumption of fat-containing food or drink, andrdiovascular Surgery c Volume 146, Number 3 571
FIGURE 1. Low-fat diet management strategy for postoperative chylo-
thorax. OK-432 refers to a heat- and penicillin-treated lyophilized prepara-
tion of the Su strain of Streptococcus pyogenes A3.
Abbreviation and Acronym
TPN ¼ total parenteral nutrition
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was monitored by our hospital nutritionist. If the volume of chylous fluid
observed was>500 mL during the first 24 hours after the initiation of con-
servative therapy, immediate reoperation was performed. If the volume re-
mained>300mL/day 3 days after the chylothorax diagnosis, we performed
pleurodesis by injecting a mixture of 10 Klinische Einheit units of OK-432
(a heat- and penicillin-treated lyophilized preparation of the Su strain of
Streptococcus pyogenes A3; Picibanil; Chugai Pharmaceutical, Tokyo, Ja-
pan), 10 mL of 1% lidocaine, and 50 mL isotonic saline into the thoracic
cavity through a chest tube. If the chest tube drainage was<300 ml/day af-
ter 3 days, the patients continued the low-fat diet. If the chylothorax had not
been cured within about 2 weeks with this conservative strategy, surgical
intervention was performed. A patient was considered curedwhen the chest
tube drainage fluid was serous, the volume was<200 mL/day, and if the
fluid did not become chylous even after the patient had eaten fatty ice
cream. We challenged with ice cream on the first day the chest tube output
was<200 ml/day and serous.
The present study was a retrospective analysis of prospectively col-
lected patient data after the diagnosis of chylothorax from October 2003
toMarch 2010. Data from the patients with chylothoraxwere collected pro-
spectively. The diagnosis and management protocol was implemented in
2003 and used uniformly for all eligible patients, whose operations were
performed by the 4 attending surgeons, for the entire study period. The
medical records of these patients were reviewed for age, gender, disease
laterality, surgical procedures, chest tube drainage amount, treatment
course, and length of hospital stay. The institutional review board approved
the data collection and analyses and waived the need to obtain written in-
formed consent from each patient in March 2011.RESULTS
Of the 37 patients, 33 were men and 4 were women. Their
age ranged from 44 to 88 years (median, 69). The initial
procedure was right pneumonectomy in 1 patient (3%)
and lobectomy in 36 patients (97%). Lobectomy on the
right side was performed in 27 patients (73%), including
20 upper lobectomies (54%), 5 lower lobectomies (14%),
and 2 middle lobectomies (5%). Lobectomy on the left
side was performed in 9 patients (24%), including 6 upper
lobectomies (16%) and 3 lower lobectomies (8%; Table 1).
Three patients received induction therapy (1 chemotherapy
and 2 concurrent chemoradiotherapy). Initial surgery was
performed with video thoracoscopic assistance in 34 pa-
tients (84%; Table 1). The pathologic lymph node metasta-
ses were stage pN0 in 31 patients (84%), pN1 in 3 patients
(8%), and pN2 in 3 patients (8%).
Of these 37 patients, 4 (11%) underwent immediate sur-
gery, because the volume of chest tube drainage chylous
fluid was>500 mL during the first 24 hours of a low-fat
diet (Figure 2).
The remaining 33 patients continuedwith the low-fat diet,
and in 23 (62%), the condition resolved. However, because
of a continuous chylous fluid volume of>300 mL/day 3572 The Journal of Thoracic and Cardiovascular Surgdays after the chylothorax diagnosis, 10 patients (27%) un-
derwent pleurodesis with the OK-432 mixture. After pleu-
rodesis, the condition resolved in 8 patients (22%). The
remaining 2 patients underwent reoperation, because their
chylothorax had not been cured by approximately 2 weeks
after the initiation of the current conservative therapy.
In all, 6 patients (16%) underwent reoperation (4 imme-
diately and 2 after pleurodesis) with thoracoscopic
assistance. The initial surgery of these 6 patients was
right-sided lobectomy with mediastinal lymph node dissec-
tion. Injury to the thoracic duct was indentified in 3 patients,
and the injuries were sutured and covered with a Tacho-
Comb fibrinogen tissue sealing sheet (CSL Behring, Tokyo,
Japan). In all cases, the thoracic duct was ligated at the level
of the diaphragm. After reoperation, the chest tube drainage
decreased, and the chylothorax was cured in 5 patients at
a median of 10 days (range, 3-10) after reoperation and
a median of 13 days (range, 6-16) after the initial surgery.
However, 1 patient required additional pleurodesis because
of continued chylous leakage. His chylothorax was diag-
nosed as cured and the chest tubewas removed 21 days after
the initial surgery (18 days after the chylothorax surgery).
In total, postoperative chylothorax was conservatively
cured in 31 patients (84%) and their chest tube was re-
moved a median of 10 days (range, 5-20) after the initial
surgery. In these 31 patients, 8 patients underwent pleurod-
esis and were cured without surgery. Their chest tubes were
removed a median of 13 days (range, 5-18) after their initial
surgery. In the remaining 23 patients treated with the low-
fat diet alone, their chest tubes were removed at a median
of 8 days (range, 5-20). The remaining 6 patients (16%) un-
derwent reoperation, the condition resolved, and their chest
tube was removed a median of 13 days (range, 6-21) after
the initial surgery. No 30-day or in-hospital deaths occurred
in any patients. Finally, 2 patients developed arrhythmia, 2ery c September 2013
TABLE 1. Patient characteristics
Characteristic Value
Age (yr)
Median 69
Range 44-88
Gender (n)
Men 33 (89)
Women 4 (11)
Induction therapy (n)
Yes 3 (8)
Concurrent chemoradiotherapy 2
Chemotherapy 1
No 34 (84)
Initial operation (n)
Lobectomy on right 27 (73)
Upper lobectomy 20 (54)
Lower lobectomy 5 (14)
Middle lobectomy 2 (5)
Lobectomy on left 9 (24)
Upper lobectomy 6 (16)
Lower lobectomy 3 (8)
Right pneumonectomy 1 (3)
Video thoracoscopic assistance (n)
Yes 34 (84)
No 3 (8)
Pathologic N stage (n)
N0 31 (84)
N1 3 (8)
N2 3 (8)
Pathologic stage (UICC 6th edition) (n)
IA 14 (38)
IB 9 (24)
IIA 1 (3)
IIB 7 (19)
IIIA 4 (11)
IIIB 2 (5)
Data in parentheses are percentages. UICC, International Union Against Cancer.
Low fat diet 
(fat < 10 g/day)
Lobectomy or greater + node 
dissection for primary lung cancer
n = 1580 
Postoperative chylothorax
n = 37
Cured
Surgically cured
n = 6
Conservatively cured
n = 31
OK432 pleurodesis
1st 24-hr drainage 
> 500 mL
Immediate
surgery
Yes: n=4 No: n = 33
Drainage > 300 mL/day 
after 3 days
Yes: n=10
No: n=23
n=2
n=8
n=4
Surgery needed 
FIGURE 2. Chylothorax management strategy and outcomes.
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patients were treated conservatively and were cured.
DISCUSSION
Chyle duct injury with resulting postoperative chylo-
thorax is a relatively rare complication of thoracic surgery.
Iatrogenic chylothorax occurs in 0.25% to 0.5% of all thoracic
surgery cases and has also been described in association
with neck dissection, cardiac surgery, pulmonary resection,
and esophagectomy.2-4 In the present study, the incidence
rate of iatrogenic chylothorax was much higher than that
described in previous reports. This might have been
because all the patients in the present series had
undergone systematic mediastinal lymph node dissection,
as previously described.5
The nutritional state of postoperative patients with
chylothorax can deteriorate quickly, resulting in poor
immunologic status and thoracic infection; therefore, theThe Journal of Thoracic and Cacondition needs to be rapidly and effectively managed.
The strategy of conservative treatment includes the reduc-
tion of the chyle flow, inflating the lung, decreasing the
dead space in the thoracic cavity, nutritional support, and
the prevention of septic complications.6 Thoracic duct
chyle flow increases after eating, in particular after
a high-fat meal.7 The volume of chyle flow can be reduced
by avoiding fat-containing enteral nutrition.8 Therefore,
complete oral intake cessation, with TPN or a low-fat
diet, has often been recommended. However, TPN can be
associated with complications such as venous line infection
and mucosal integrity disorder. In contrast, oral intake and
enteral nutrition have been reported to be safe and more nat-
ural, with fewer complications.9,10 Despite these reported
advantages of enteral feeding, many studies of the
conservative management of chylothorax have suggested
the use of TPN was more effective than a low-fat
diet.3,11,12 We also reported successful chylothorax
management using TPN, with complete oral intake
cessation in 2002.1
However, several researchers have recently reported the
advantages of a low-fat diet in reducing the thoracic duct
flow of chyle.13-15 On the basis of their findings and our
previously reported experience,1 we have developed
a low-fat diet management strategy for postoperative chylo-
thorax, with surgical intervention if the chest tube dischargerdiovascular Surgery c Volume 146, Number 3 573
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strategy of a low-fat diet cured 31 patients (84%) at a me-
dian of 10 days (range, 5-20) after the initial lung resection.
Compared with our previous strategy of complete oral in-
take cessation and TPN, with which 81% of the patients
were cured at a median of 8 days (range, 4-35) after the chy-
lothorax diagnosis,1 we believe this new strategy is also ef-
fective, with the least amount of burden to the patient. Of
the 10 patients who required pleurodesis with the OK-432
mixture, the condition was cured in 8 (80%) without surgi-
cal intervention. Together with our previous report, in
which 13 of the 15 patients (87%) receiving OK-432 pleu-
rodesis were cured, we have demonstrated that pleurodesis
is an effective adjunct in patients in whom excessive drain-
age discharge persists even after 3 days of reduced thoracic
duct flow.
Surgical repair should be considered only when it has be-
come clear that conservative treatment has failed. The clin-
ical parameters that prompt surgical intervention have
varied among reports.16,17 We previously reported that
chest tube drainage discharge of>500 mL during the first
24 hours after complete oral intake cessation and TPN
predicted continued leakage, and, therefore, an immediate
reoperation might be indicated.1 In the present study, we
considered surgical intervention necessary if the chest
tube drainage during the first 24 hours after the initiation
of a low-fat diet was>500 mL, or if the patient’s chylo-
thorax was not cured within about 2 weeks with conserva-
tive treatment. We performed reoperation in 6 patients
(16%; 4 immediately and 2 after pleurodesis). Even in these
surgically treated patients, cure was achieved and the chest
tube was removed at a reasonable median of 13 days (range,
6-21) from the initial surgery.
The present study had some limitations. In particular, the
patients were drawn from only 1 institution and from a gen-
erally homogenous ethnic group. Furthermore, although we
achieved 80% cure, the number of patients was small. Be-
cause no control group was included, it would be difficult to
draw strong conclusions about the efficacy of our approach.
However, in conclusion,>80% of chylothorax cases af-
ter pulmonary resection with mediastinal lymph node dis-
section could be cured with our low-fat diet management
strategy. Reoperation was indicated for <20% of the574 The Journal of Thoracic and Cardiovascular Surgpatients, which minimized the overall number of days
needed until a cure was obtained. These results were similar
to the outcomes of our previous strategy of TPN and com-
plete oral intake cessation.1 Our chylothorax management
strategy with a low-fat diet was effective, with a minimal
patient burden.
We are indebted to Assistant Professor Rod Turner of Toho Uni-
versity Medical School and Professor J. Patrick Barron, Chair of
the Department of International Medical Communications at
Tokyo Medical University, for their editorial review of our report.
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